In patients with NSCLC, there was no significant difference in marker serum levels between any of the stages except for a higher level of CXCL10 in stage IV patients versus those with stage I. However, the levels of all markers were significantly higher in stage IV NSCLC patients than in patients with stages I–III combined. The gene discussed is CXCL10; the disease is non-small cell lung carcinoma.